Xiao Weihua, Chen Qiong, Liu Chunjiao, Yu Yueer, Liu Tianliang, Jin Yang, Ma Haifen, Chen Shifu, Jiang Chao
Department of Pathology, Beilun Branch of the First Affiliated Hospital, College of Medicine Zhejiang University Ningbo China.
MOE Key Laboratory of Biosystems Homeostasis & Protection, and Zhejiang Key Laboratory of Molecular Cancer Biology, Life Sciences Institute Zhejiang University Hangzhou China.
Imeta. 2025 Mar 19;4(2):e70017. doi: 10.1002/imt2.70017. eCollection 2025 Apr.
The gut microbiota-cancer interaction functions through multi-level biological mechanisms, forming the basis for both diagnostic and therapeutic applications. Current technical and biological challenges drive the field toward precision medicine approaches, aiming to integrate multi-dimensional data for optimized, personalized cancer treatments.
肠道微生物群与癌症的相互作用通过多层次的生物学机制发挥作用,构成了诊断和治疗应用的基础。当前的技术和生物学挑战推动该领域朝着精准医学方法发展,旨在整合多维度数据以实现优化的个性化癌症治疗。